Long-term outcomes of bariatric surgery in patients with diabetes

References

• Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007 Aug;357(8):741–752.
   PubMed Web of Science ®Google Scholar
• Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008 Jan;299(3):316–323.
   PubMed Web of Science ®Google Scholar
• Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes. N Engl J Med. 2017 02; 376(7): 641–651.
   PubMed Web of Science ®Google Scholar
• Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012 Apr;366(17):1577–1585.
   PubMed Web of Science ®Google Scholar
• Ikramuddin S, Korner J, Lee WJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA. 2013 Jun;309(21):2240–2249.
   PubMed Web of Science ®Google Scholar
• Kashyap SR, Bhatt DL, Wolski K, et al. Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment. Diabetes Care. 2013 Aug;36(8):2175–2182.
   PubMed Web of Science ®Google Scholar
• Courcoulas AP, Goodpaster BH, Eagleton JK, et al. Surgical vs medical treatments for type 2 diabetes mellitus: a randomized clinical trial. JAMA Surg. 2014 Jul;149(7):707–715.
   PubMed Web of Science ®Google Scholar
• Halperin F, Ding SA, Simonson DC, et al. Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial. JAMA Surg. 2014 Jul;149(7):716–726.
   PubMed Web of Science ®Google Scholar
• Simonson DC, Halperin F, Foster K, et al. Clinical and Patient-Centered Outcomes in Obese Patients With Type 2 Diabetes 3 Years After Randomization to Roux-en-Y Gastric Bypass Surgery Versus Intensive Lifestyle Management: the SLIMM-T2D Study. Diabetes Care. 2018 04; 41(4): 670–679.
   PubMed Web of Science ®Google Scholar
• Liang Z, Wu Q, Chen B, et al. Effect of laparoscopic Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus with hypertension: a randomized controlled trial. Diabetes Res Clin Pract. 2013 Jul;101(1):50–56.
   PubMed Web of Science ®Google Scholar
• Wentworth JM, Playfair J, Laurie C, et al. Multidisciplinary diabetes care with and without bariatric surgery in overweight people: a randomised controlled trial. Lancet Diabetes Endocrinol. 2014 Jul;2(7):545–552.
   PubMed Web of Science ®Google Scholar
• Cummings DE, Arterburn DE, Westbrook EO, et al. Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial. Diabetologia. 2016 May;59(5):945–953.
   PubMed Web of Science ®Google Scholar
• Parikh M, Chung M, Sheth S, et al. Randomized pilot trial of bariatric surgery versus intensive medical weight management on diabetes remission in type 2 diabetic patients who do NOT meet NIH criteria for surgery and the role of soluble RAGE as a novel biomarker of success. Ann Surg. 2014 Oct;260(4):617–622. discussion 622-4.
   PubMed Web of Science ®Google Scholar
• Franz MJ, Boucher JL, Rutten-Ramos S, et al. Lifestyle weight-loss intervention outcomes in overweight and obese adults with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials. J Acad Nutr Diet. 2015 Sep;115(9):1447–1463.
   PubMed Web of Science ®Google Scholar
• Davies MJ, D’Alessio DA, Fradkin J, et al. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2018 12; 41(12): 2669–2701.
   PubMed Web of Science ®Google Scholar
• Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009 Mar;122(3):248–256.e5.
   PubMed Web of Science ®Google Scholar
• Ali MK, Bullard KM, Saaddine JB, et al. Achievement of goals in U.S. diabetes care, 1999-2010. N Engl J Med. 2013 Apr;368(17):1613–1624.
   PubMed Web of Science ®Google Scholar
• Cohen RV, Shikora S, Petry T, et al. The Diabetes Surgery Summit II Guidelines: a Disease-Based Clinical Recommendation. Obes Surg. 2016 08; 26(8): 1989–1991.
   PubMed Web of Science ®Google Scholar
• Pournaras DJ, Osborne A, Hawkins SC, et al. Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes. Ann Surg. 2010 Dec;252(6):966–971.
   PubMed Web of Science ®Google Scholar
• Pournaras DJ, Aasheim ET, Bueter M, et al. Effect of bypassing the proximal gut on gut hormones involved with glycemic control and weight loss. Surg Obes Relat Dis. 2012 Jul-Aug;8(4):371–374.
   PubMed Web of Science ®Google Scholar
• Koliaki C, Liatis S, le Roux CW, et al. The role of bariatric surgery to treat diabetes: current challenges and perspectives. BMC Endocr Disord. 2017 Aug;17(1):50.
   PubMedGoogle Scholar
• Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2015 Sep;386(9997):964–973.
   PubMed Web of Science ®Google Scholar
• Brethauer SA, Aminian A, Romero-Talamás H, et al. Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg. 2013 Oct;258(4):628–636. discussion 636-7.
   PubMed Web of Science ®Google Scholar
• Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care. 2009 Nov;32(11):2133–2135.
   PubMed Web of Science ®Google Scholar
• Pournaras DJ, Aasheim ET, Søvik TT, et al. Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders. Br J Surg. 2012 Jan;99(1):100–103.
   PubMed Web of Science ®Google Scholar
• Pournaras DJ, le Roux CW. Type 2 diabetes: multimodal treatment of a complex disease. Lancet. 2015 Sep;386(9997):936–937.
   PubMed Web of Science ®Google Scholar
• Pournaras DJ, le Roux CW. Can we predict diabetes remission after weight-loss surgery? Lancet Diabetes Endocrinol. 2014 Jan;2(1):4–6.
   PubMed Web of Science ®Google Scholar
• Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008 Oct;359(15):1577–1589.
   PubMed Web of Science ®Google Scholar
• Sjöström L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004 Dec;351(26):2683–2693.
   PubMed Web of Science ®Google Scholar
• Sjöström L, Peltonen M, Jacobson P, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014 Jun;311(22):2297–2304.
   PubMed Web of Science ®Google Scholar
• Aminian A, Zajichek A, Arterburn DE, et al. Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity. JAMA. 2019 Sept;322(13):1271–1282.
   Google Scholar
• Coleman KJ, Haneuse S, Johnson E, et al. Long-term Microvascular Disease Outcomes in Patients With Type 2 Diabetes After Bariatric Surgery: evidence for the Legacy Effect of Surgery. Diabetes Care. 2016 Aug;39(8):1400–1407.
   PubMed Web of Science ®Google Scholar
• O’Brien R, Johnson E, Haneuse S, et al. Microvascular Outcomes in Patients With Diabetes After Bariatric Surgery Versus Usual Care: A Matched Cohort Study. Ann Intern Med. 2018;09;169(5):300–310.
   Web of Science ®Google Scholar
• Li K, Zou J, Ye Z, et al. Effects of Bariatric Surgery on Renal Function in Obese Patients: A Systematic Review and Meta Analysis. PLoS One. 2016;11(10):e0163907.
   PubMed Web of Science ®Google Scholar
• Iaconelli A, Panunzi S, De Gaetano A, et al. Effects of bilio-pancreatic diversion on diabetic complications: a 10-year follow-up. Diabetes Care. 2011 Mar;34(3):561–567.
   PubMed Web of Science ®Google Scholar
• Pournaras DJ, Hardwick RH, le RCW. Gastrointestinal surgery for obesity and cancer: 2 sides of the same coin. Surg Obes Relat Dis. 2017;13(4):720–721.
   PubMed Web of Science ®Google Scholar
• Sudlow A, W le Roux C, Pournaras JD. Review of Advances in Anti-obesity Pharmacotherapy: implications for a Multimodal Treatment Approach with Metabolic Surgery. Obes Surg. 2019 Dec; 29(12):4095–4104.
   Web of Science ®Google Scholar
• Sudlow A, le Roux CW, Pournaras DJ. Review of multimodal treatment for type 2 diabetes: combining metabolic surgery and pharmacotherapy. Ther Adv Endocrinol Metab. 2019;10:2042018819875407.
   Web of Science ®Google Scholar